Übersetzung für "Tail vein" in Deutsch

Peripheral blood is obtained from the tail vein or other appropriate blood vessel.

The injection is carried out via the tail vein.

The blood samples necessary for this were taken from the tail vein.

Mouse blood (obtained from the tail vein) was diluted 1:100 in isotonic glucose solution.

If necessary gently stroke tail vein to ensure blood continues to flow.

The metal complexes are administered twice weekly into the tail vein as solutions of coprecipitates in physiological saline solution.

For this purpose, tumour cells are cultivated in vitro and injected into the tail vein of the test animals.

Treatment with ADCs is carried out via the intravenouse route into the tail vein of the mouse.

Through infusion of 100 mg/kg of pentetrazole at a rate of 36 ml/hour by way of the tail vein, clonic convulsions (myoclonic convulsions) are the first to occur in mice weighing 18 to 22 g.

Then an intravenous application takes place, also by needle in the tail vein, of GdDTPA in a dose of 0.2 mmol/kg.

To do this, 500 mg/kg of body weight (2.5 mg/kg) of Triton WR-1339, dissolved in physiological saline solution, is administered intravenously into the tail vein of rats.

For this, 500 mg/kg of body weight (2.5 mg/kg) of Triton WR-1339 dissolved in physiological saline solution are administered intravenously into the tail vein of rats.

For this, 500 mg/kg of body weight (2.5 mg/kg) of Triton WR-1339, dissolved in physiological sodium chloride solution, are administered intravenously into the tail vein of rats.

Specifically pathogen-free male Wistar rats eight weeks old and weighing 200 g are infected with 5×106 CFU of Candida albicans in 0.5 ml of PBS via the lateral tail vein.

On the day of heart transplantation and then at intervals of 4 days, 1 ml of blood in each case is taken from the tail vein of the recipient rats (Lewis rats).

Male CFW1 mice of weight 20 g were infected in the tail vein by injection of 3×105 CFU of C. albicans per animal.

Eight-week old, specifically pathogen-free, male Wistar rats of weight 200 g are infected via the lateral tail vein with 5×106 CFU of Candida albicans in 0.5 ml of PBS.

On the 4th day, immediately before the substance administration, blood was taken from the tail vein for the determination of the fibrinogen.

The test substances are administered up to one hour prior to the LPS injection either intravenously via the tail vein, subcutaneously, intraperitoneally or orally using a stomach tube.

LPS (E. coli O 55 B5, manufactured by Sigma, dissolved in PBS) is administered to male Wistar rats at a dosage of 250 ?g/kg intravenously into the tail vein (administration volume 2 ml/kg).

Before the administration and four hours after the last administration of substance, 50 n1 of blood are taken from the animals from the retroorbital venous plexus or the tail vein under short narcosis.

The compound of Example 1 was dissolved in a 10% strength alcoholic solution and administered, either intravenously into the tail vein or orally.

Ex vivo bio-distribution studies are conducted in groups of 4 mice each, in which 555 kBq In-111 labeled MC10 is injected into the tail vein.

After the injection into the tail vein of mice all QDs distribute rapidly within the blood circulation even though various coatings have been used.

At the end of the study, blood is taken from the animals from the venous plexus of the corner of the eye or the tail vein under short narcosis and is rendered uncoagulable by addition of sodium citrate.